Pharmacology Clear and Simple-
C C C
C A Guide to Drug Classifications and DosageCalculations 3rd
C C C C C C C C C
Edition Watkins Test Bank
C C C
ChapterC 1.C HistoryC ofC Pharmacology
1.
AC nurseC workingC inC radiologyC administersC iodineC toC aC patientC whoC isC havi
ngC aCcomputedC tomographyC (CT)C scan.C TheC nurseC workingC onC theC oncologyC
unitCadministersC chemotherapyC toC patientsC whoC haveC cancer.C AtC theC PublicC
HealthCDepartment,C aC nurseC administersC aC measles-mumps-
rubellaC (MMR)C vaccineCtoC aC 14-month-
oldCchildC asC aC routineCimmunization.C WhichC branchC ofCpharmacologyCbestCde
scribesCtheCactionsCofCallCthreeCnurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
Ans: B
Feedback:
PharmacologyC isC theC studyC ofC theC biologicC effectsC ofC chemicals.C NursesC areCi
nvolvedC withC clinicalC pharmacologyC orC pharmacotherapeutics,C whichC isC aCbr
anchC ofC pharmacologyC thatC dealsC withC theC usesC ofC drugsC toC treat,C prevent,Can
dC diagnoseC disease.C TheC radiologyC nurseC isC administeringC aC drugC toC helpCdia
gnoseC aC disease.C TheC oncologyC nurseC isC administeringC aC drugC toC helpC treatCaC
disease.C PharmacoeconomicsC includesC anyC costsC involvedC inC drugC therapy.CP
harmacodynamicsCinvolvesChowCaCdrugCaffectsCtheCbodyCandCpharmacokineti
csCisChowCtheCbodyCactsConCtheCbody.
2.
AC physicianC hasC orderedC intramuscularC (IM)C injectionsC ofC morphine,C aCna
rcotic,C everyC 4C hoursC asC neededC forC painC inC aC motorC vehicleCaccidentCvictim.
C TheC nurseC isC awareC thisC drugC hasC aC highC abuseC potential.C UnderC whatC
categ
oryCwouldCmorphineCbeCclassified?
A) ScheduleC I
B) ScheduleC II
C) ScheduleC III
D) ScheduleC IV
Ans: B
, Feedback:
NarcoticsC withC aC highCabuseC potentialCareC classifiedCasC ScheduleC IIC drugsCbec
auseC ofC severeC dependenceC liability.C ScheduleC IC drugsC haveC highC abuseCpoten
tialC andC noC acceptedC medicalC use.C ScheduleC IIIC drugsC haveC aC lesserCabuseC po
tentialC thanC IIC andC anC acceptedC medicalC use.C ScheduleC IVC drugsC haveClowCab
useCpotentialCandClimitedCdependenceCliability.
3.
WhenC involvedC inC phaseC IIIC drugC evaluationC studies,C whatC responsibili
tiesCwouldCtheCnurseChave?
A) WorkingC withC animalsC whoC areC givenC experimentalC drugs
B) ChoosingC appropriateC patientsC toC beC involvedC inC theC drugC study
C) MonitoringC andC observingC patientsC closelyC forC adverseC effects
D) ConductingC researchC toC determineC effectivenessC ofC theC drug
Ans: C
Feedback:
PhaseC IIIC studiesC involveC useC ofC aC drugC inC aC vastC clinicalC populationC inC whic
hCpatientsC areC askedC toC recordC anyC symptomsC theyC experienceC whileC takingC t
heCdrugs.C NursesC mayC beC responsibleC forC helpingC collectC andCanalyzeC theCinfo
rmationC toC beC sharedC withC theC FoodC andC DrugC AdministrationC (FDA)C butCwo
uldC notC conductC researchC independentlyC becauseC nursesC doC notC prescribeCme
dications.C UseC ofC animalsC inC drugC testingC isC doneC inC theC preclinicalC trials.CSe
lectC patientsC whoC areC involvedC inC phaseC IIC studiesC toC participateC inC studiesCw
hereC theC participantsC haveC theC diseaseC theC drugC isC intendedC toC treat.C TheseCpa
tientsC areC monitoredC closelyC forC drugC actionC andC adverseC effects.C PhaseC ICstu
diesC involveC healthyC humanC volunteersC whoC areC usuallyC paidC forC theirCpartici
pation.C NursesCmayC observeC forC adverseCeffectsC andC toxicity.
4.
WhatC conceptC isC consideredC whenC genericC drugsC areC substitutedC forC br
andCnameCdrugs?
A) Bioavailability
B) CriticalC concentration
C) Distribution
D) Half-life
Ans: A
Feedback:
, BioavailabilityC isC theC portionC ofC aC doseC ofC aC drugC thatC reachesC theC systemicCc
irculationC andC isC availableC toC actC onC bodyC cells.C BindersC usedC inC aC genericCdr
ugC mayC notC beC theC sameC asC thoseC usedC inC theC brandC nameC drug.C Therefore,Ct
heC wayC theC bodyC breaksC downC andC usesCtheC drugC mayC differ,C whichCmayCeli
minateC aC genericC drugC substitution.C CriticalC concentrationC isC theC amountC ofCa
C drugC thatC isC neededC toC causeC aC therapeuticC effectC andC shouldC notC differCbetw
eenC genericC andC brandC nameC medications.C DistributionC isC theC phaseC ofCphar
macokinetics,C whichCinvolvesC theC movementC ofC aC drugC toC theC bodysCtissuesC
andC isC theC sameC inC genericC andC brandC nameC drugs.C AC drugsC half-
lifeC isCtheCtimeCitCtakesC forC theCamountC ofC drugC toC decreaseC toC halfC theC peakC l
evel,CwhichCshouldCnotCchangeCwhenCsubstitutingCaCgenericCmedication.
5.
AC nurseC isC assessingC theC patientsC homeC medicationC use.C AfterC listeningC to
C theCpatientC listC currentCmedications,C theC nurseCasksC whatC priorityC question?
A) DoC youC takeC anyC genericC medications?
B) AreC anyC ofC theseC medicationsC orphanC drugs?
C) AreC theseC medicationsC safeC toC takeC duringC pregnancy?
D) DoC youC takeC anyC over-the-counterC medications?
Ans: D
Feedback:
ItC isC importantC forC theC nurseC toC specificallyC questionC useC ofC over-the-
counterCmedicationsC becauseC patientsC mayC notC considerC themC important.C Th
eC patientCisC unlikelyC toC knowC theC meaningC ofC orphanC drugsC unlessC theyC tooC a
reC healthCcareC providers.CSafetyC duringC pregnancy,C useC ofC aC genericC medicati
on,C orCclassificationC ofC orphanC drugsC areC thingsC theCpatientC wouldC beC unableC
toCanswerC butC couldC beC foundC inC referenceC booksC ifC theC nurseC wishesC toC rese
archCthem.
6.
AfterC completingC aC courseC onC pharmacologyC forC nurses,C whatC willC theC n
urseCknow?
A) EverythingC necessaryC forC safeC andC effectiveC medicationC administration
B)
CurrentC pharmacologicC therapy;C theC nurseC willC notC requireC o
ngoingCeducationCforC5Cyears.
C)
GeneralC drugC information;C theC nurseC canC consultC aC drugC guideC forC
specificCdrugCinformation.
D)
TheC drugC actionsC thatC areC associatedC withC eachC classific
ationC ofCmedication
Ans: C
Feedback:
, AfterC completingC aC pharmacologyC courseC nursesC willC haveC generalC drugCinfo
rmationC neededC forC safeC andC effectiveC medicationC administrationC butC willCne
edCtoCconsultCaCdrugCguideCforCspecificCdrugCinformationCbeforeCadministerin
gC anyC medication.C PharmacologyC isC constantlyC changing,C withCnewC drugsC en
teringC theC marketC andC newC usesC forC existingC drugsC identified.
ContinuingC educationC inC pharmacologyC isC essentialC toC safeC practice.C NursesCt
endC toC becomeC familiarC withC theC medicationsC theyC administerC mostC often,C bu
tCthereC willC alwaysC beC aC needC toC researchC newC drugsC andC alsoC thoseC theC nurseC
isCnotCfamiliarCwithCbecauseCnoCnurseCknowsCallCmedications.
7.
ACnurseCisCinstructingCaCpregnantCpatientCconcerningCtheCpotentialCriskCtoCh
erCfetusCfromCaCPregnancyCCategoryCBCdrug.CWhatCwouldCtheCnurseCinformCt
heCpatient?
A)
AdequateC studiesC inC pregnantC womenC haveC demonstratedC thereC isC
noC riskCtoCtheCfetus.
B)
AnimalC studiesC haveC notC demonstratedC aC riskC toC theC fetus,C butC the
reC haveCbeenCnoCadequateCstudiesCinCpregnantCwomen.
C)
AnimalC studiesC haveC shownC anC adverseC effectC onC theC fetus,C butC t
hereC areCnoCadequateCstudiesCinCpregnantCwomen.
D)
ThereC isC evidenceC ofC humanC fetalC risk,C butC theC potentialC benefitsC fr
omC useCofCtheCdrugCmayCbeCacceptableCdespiteCpotentialCrisks.
Ans: B
Feedback:
CategoryC BC indicatesC thatC animalC studiesC haveC notC demonstratedC aC riskC toC th
eCfetus.C However,C thereC haveC notC beenC adequateC studiesC inC pregnantC womenC
toCdemonstrateC riskC toCaC fetusC duringC theC firstC trimesterC ofC pregnancyC andC no
CevidenceC ofC riskC inC laterC trimesters.C CategoryC AC indicatesC thatC adequateCstu
diesC inC pregnantC womenC haveC notC demonstratedC aC riskC toC theC fetusC inC theCfir
stC trimesterC orC inC laterC trimesters.C CategoryC CC indicatesC thatC animalC studiesCh
aveCshownC anC adverseC effectConCtheC fetus,C butCnoC adequateC studiesCinChuman
s.C CategoryC DC revealsC evidenceC ofC humanC fetalC risk,C butC theC potentialCbenefi
tsCfromCtheC useCofC theCdrugsC inCpregnantC womenCmayC outweighCpotentialCris
ks.
8.
DischargeCplanningC forCpatientsC leavingCtheC hospitalCshouldCincludeCinstruc
tionsC onC theC useC ofC over-the-
counterC (OTC)C drugs.C WhichC commentC byCtheC patientC wouldC demonstrateCaC g
oodC understandingC ofC OTCC drugs?
A) OTCC drugsC areC safeC andC doC notC causeC adverseC effectsC ifC takenC properly.
C C C
C A Guide to Drug Classifications and DosageCalculations 3rd
C C C C C C C C C
Edition Watkins Test Bank
C C C
ChapterC 1.C HistoryC ofC Pharmacology
1.
AC nurseC workingC inC radiologyC administersC iodineC toC aC patientC whoC isC havi
ngC aCcomputedC tomographyC (CT)C scan.C TheC nurseC workingC onC theC oncologyC
unitCadministersC chemotherapyC toC patientsC whoC haveC cancer.C AtC theC PublicC
HealthCDepartment,C aC nurseC administersC aC measles-mumps-
rubellaC (MMR)C vaccineCtoC aC 14-month-
oldCchildC asC aC routineCimmunization.C WhichC branchC ofCpharmacologyCbestCde
scribesCtheCactionsCofCallCthreeCnurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
Ans: B
Feedback:
PharmacologyC isC theC studyC ofC theC biologicC effectsC ofC chemicals.C NursesC areCi
nvolvedC withC clinicalC pharmacologyC orC pharmacotherapeutics,C whichC isC aCbr
anchC ofC pharmacologyC thatC dealsC withC theC usesC ofC drugsC toC treat,C prevent,Can
dC diagnoseC disease.C TheC radiologyC nurseC isC administeringC aC drugC toC helpCdia
gnoseC aC disease.C TheC oncologyC nurseC isC administeringC aC drugC toC helpC treatCaC
disease.C PharmacoeconomicsC includesC anyC costsC involvedC inC drugC therapy.CP
harmacodynamicsCinvolvesChowCaCdrugCaffectsCtheCbodyCandCpharmacokineti
csCisChowCtheCbodyCactsConCtheCbody.
2.
AC physicianC hasC orderedC intramuscularC (IM)C injectionsC ofC morphine,C aCna
rcotic,C everyC 4C hoursC asC neededC forC painC inC aC motorC vehicleCaccidentCvictim.
C TheC nurseC isC awareC thisC drugC hasC aC highC abuseC potential.C UnderC whatC
categ
oryCwouldCmorphineCbeCclassified?
A) ScheduleC I
B) ScheduleC II
C) ScheduleC III
D) ScheduleC IV
Ans: B
, Feedback:
NarcoticsC withC aC highCabuseC potentialCareC classifiedCasC ScheduleC IIC drugsCbec
auseC ofC severeC dependenceC liability.C ScheduleC IC drugsC haveC highC abuseCpoten
tialC andC noC acceptedC medicalC use.C ScheduleC IIIC drugsC haveC aC lesserCabuseC po
tentialC thanC IIC andC anC acceptedC medicalC use.C ScheduleC IVC drugsC haveClowCab
useCpotentialCandClimitedCdependenceCliability.
3.
WhenC involvedC inC phaseC IIIC drugC evaluationC studies,C whatC responsibili
tiesCwouldCtheCnurseChave?
A) WorkingC withC animalsC whoC areC givenC experimentalC drugs
B) ChoosingC appropriateC patientsC toC beC involvedC inC theC drugC study
C) MonitoringC andC observingC patientsC closelyC forC adverseC effects
D) ConductingC researchC toC determineC effectivenessC ofC theC drug
Ans: C
Feedback:
PhaseC IIIC studiesC involveC useC ofC aC drugC inC aC vastC clinicalC populationC inC whic
hCpatientsC areC askedC toC recordC anyC symptomsC theyC experienceC whileC takingC t
heCdrugs.C NursesC mayC beC responsibleC forC helpingC collectC andCanalyzeC theCinfo
rmationC toC beC sharedC withC theC FoodC andC DrugC AdministrationC (FDA)C butCwo
uldC notC conductC researchC independentlyC becauseC nursesC doC notC prescribeCme
dications.C UseC ofC animalsC inC drugC testingC isC doneC inC theC preclinicalC trials.CSe
lectC patientsC whoC areC involvedC inC phaseC IIC studiesC toC participateC inC studiesCw
hereC theC participantsC haveC theC diseaseC theC drugC isC intendedC toC treat.C TheseCpa
tientsC areC monitoredC closelyC forC drugC actionC andC adverseC effects.C PhaseC ICstu
diesC involveC healthyC humanC volunteersC whoC areC usuallyC paidC forC theirCpartici
pation.C NursesCmayC observeC forC adverseCeffectsC andC toxicity.
4.
WhatC conceptC isC consideredC whenC genericC drugsC areC substitutedC forC br
andCnameCdrugs?
A) Bioavailability
B) CriticalC concentration
C) Distribution
D) Half-life
Ans: A
Feedback:
, BioavailabilityC isC theC portionC ofC aC doseC ofC aC drugC thatC reachesC theC systemicCc
irculationC andC isC availableC toC actC onC bodyC cells.C BindersC usedC inC aC genericCdr
ugC mayC notC beC theC sameC asC thoseC usedC inC theC brandC nameC drug.C Therefore,Ct
heC wayC theC bodyC breaksC downC andC usesCtheC drugC mayC differ,C whichCmayCeli
minateC aC genericC drugC substitution.C CriticalC concentrationC isC theC amountC ofCa
C drugC thatC isC neededC toC causeC aC therapeuticC effectC andC shouldC notC differCbetw
eenC genericC andC brandC nameC medications.C DistributionC isC theC phaseC ofCphar
macokinetics,C whichCinvolvesC theC movementC ofC aC drugC toC theC bodysCtissuesC
andC isC theC sameC inC genericC andC brandC nameC drugs.C AC drugsC half-
lifeC isCtheCtimeCitCtakesC forC theCamountC ofC drugC toC decreaseC toC halfC theC peakC l
evel,CwhichCshouldCnotCchangeCwhenCsubstitutingCaCgenericCmedication.
5.
AC nurseC isC assessingC theC patientsC homeC medicationC use.C AfterC listeningC to
C theCpatientC listC currentCmedications,C theC nurseCasksC whatC priorityC question?
A) DoC youC takeC anyC genericC medications?
B) AreC anyC ofC theseC medicationsC orphanC drugs?
C) AreC theseC medicationsC safeC toC takeC duringC pregnancy?
D) DoC youC takeC anyC over-the-counterC medications?
Ans: D
Feedback:
ItC isC importantC forC theC nurseC toC specificallyC questionC useC ofC over-the-
counterCmedicationsC becauseC patientsC mayC notC considerC themC important.C Th
eC patientCisC unlikelyC toC knowC theC meaningC ofC orphanC drugsC unlessC theyC tooC a
reC healthCcareC providers.CSafetyC duringC pregnancy,C useC ofC aC genericC medicati
on,C orCclassificationC ofC orphanC drugsC areC thingsC theCpatientC wouldC beC unableC
toCanswerC butC couldC beC foundC inC referenceC booksC ifC theC nurseC wishesC toC rese
archCthem.
6.
AfterC completingC aC courseC onC pharmacologyC forC nurses,C whatC willC theC n
urseCknow?
A) EverythingC necessaryC forC safeC andC effectiveC medicationC administration
B)
CurrentC pharmacologicC therapy;C theC nurseC willC notC requireC o
ngoingCeducationCforC5Cyears.
C)
GeneralC drugC information;C theC nurseC canC consultC aC drugC guideC forC
specificCdrugCinformation.
D)
TheC drugC actionsC thatC areC associatedC withC eachC classific
ationC ofCmedication
Ans: C
Feedback:
, AfterC completingC aC pharmacologyC courseC nursesC willC haveC generalC drugCinfo
rmationC neededC forC safeC andC effectiveC medicationC administrationC butC willCne
edCtoCconsultCaCdrugCguideCforCspecificCdrugCinformationCbeforeCadministerin
gC anyC medication.C PharmacologyC isC constantlyC changing,C withCnewC drugsC en
teringC theC marketC andC newC usesC forC existingC drugsC identified.
ContinuingC educationC inC pharmacologyC isC essentialC toC safeC practice.C NursesCt
endC toC becomeC familiarC withC theC medicationsC theyC administerC mostC often,C bu
tCthereC willC alwaysC beC aC needC toC researchC newC drugsC andC alsoC thoseC theC nurseC
isCnotCfamiliarCwithCbecauseCnoCnurseCknowsCallCmedications.
7.
ACnurseCisCinstructingCaCpregnantCpatientCconcerningCtheCpotentialCriskCtoCh
erCfetusCfromCaCPregnancyCCategoryCBCdrug.CWhatCwouldCtheCnurseCinformCt
heCpatient?
A)
AdequateC studiesC inC pregnantC womenC haveC demonstratedC thereC isC
noC riskCtoCtheCfetus.
B)
AnimalC studiesC haveC notC demonstratedC aC riskC toC theC fetus,C butC the
reC haveCbeenCnoCadequateCstudiesCinCpregnantCwomen.
C)
AnimalC studiesC haveC shownC anC adverseC effectC onC theC fetus,C butC t
hereC areCnoCadequateCstudiesCinCpregnantCwomen.
D)
ThereC isC evidenceC ofC humanC fetalC risk,C butC theC potentialC benefitsC fr
omC useCofCtheCdrugCmayCbeCacceptableCdespiteCpotentialCrisks.
Ans: B
Feedback:
CategoryC BC indicatesC thatC animalC studiesC haveC notC demonstratedC aC riskC toC th
eCfetus.C However,C thereC haveC notC beenC adequateC studiesC inC pregnantC womenC
toCdemonstrateC riskC toCaC fetusC duringC theC firstC trimesterC ofC pregnancyC andC no
CevidenceC ofC riskC inC laterC trimesters.C CategoryC AC indicatesC thatC adequateCstu
diesC inC pregnantC womenC haveC notC demonstratedC aC riskC toC theC fetusC inC theCfir
stC trimesterC orC inC laterC trimesters.C CategoryC CC indicatesC thatC animalC studiesCh
aveCshownC anC adverseC effectConCtheC fetus,C butCnoC adequateC studiesCinChuman
s.C CategoryC DC revealsC evidenceC ofC humanC fetalC risk,C butC theC potentialCbenefi
tsCfromCtheC useCofC theCdrugsC inCpregnantC womenCmayC outweighCpotentialCris
ks.
8.
DischargeCplanningC forCpatientsC leavingCtheC hospitalCshouldCincludeCinstruc
tionsC onC theC useC ofC over-the-
counterC (OTC)C drugs.C WhichC commentC byCtheC patientC wouldC demonstrateCaC g
oodC understandingC ofC OTCC drugs?
A) OTCC drugsC areC safeC andC doC notC causeC adverseC effectsC ifC takenC properly.
